NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
9.63
+1.15 (13.56%)
Sep 10, 2025, 2:53 PM - Market open
NTHI Employees
NeOnc Technologies Holdings had 8 employees as of December 31, 2023.
Employees
8
Change
n/a
Growth
n/a
Revenue / Employee
$7,499
Profits / Employee
-$5,305,459
Market Cap
184.50M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NTHI News
- 16 days ago - NeOnc Technologies Closes Strategic Acquisition of Advanced AI and 3D Bioprinting IP, Appointing World-Renowned Scientist Dr. Ishwar K. Puri to its Board - GlobeNewsWire
- 4 weeks ago - NeOnc Technologies Finalizes All Contingencies for $50 Million Strategic Partnership with Quazar Investment as NuroMENA Holdings Receives ADGM Incorporation - GlobeNewsWire
- 4 weeks ago - NeOnc Technologies Awarded $2.5 Million in NIH STTR Grants to Advance NEO212 in Gliomas and Leukemia - GlobeNewsWire
- 5 weeks ago - NeOnc Technologies Featured on Yahoo Finance's Podcast Trader Talk: AI and Biotech Take on Brain Cancer - GlobeNewsWire
- 6 weeks ago - NeOnc Technologies Signs Definitive Agreement to Acquire AI, 3D, and Quantum Modeling IP Portfolio from Dr. Ishwar K. Puri; Appoints Him to Board of Directors - GlobeNewsWire
- 7 weeks ago - CORRECTING and REPLACING - NeOnc Technologies Holdings, Inc. - GlobeNewsWire
- 2 months ago - NeOnc Technologies Signs $50 Million Non-Binding Strategic Term Sheet with Quazar Investment to Launch GCC & MENA Expansion and Clinical Trials Platform - GlobeNewsWire
- 3 months ago - NeOnc Technologies Holdings, Inc. Appoints Dr. Josh Neman as Chief Clinical Officer to Advance Clinical Strategy and Translational Oncology Programs - GlobeNewsWire